CSPAM
CVS icon

Cary Street Partners Asset Management’s CVS Health CVS Stock Holding History

Cary Street Partners Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70,397
Closed -$5.61M – 205
2024
Q1 		$5.61M Sell
70,397
-2,623
-4% -$200K 0.87% 27
2023
Q4 		$5.77M Sell
73,020
-543
-0.7% -$38.6K 0.99% 24
2023
Q3 		$5.14M Buy
73,563
+491
+0.7% +$34.8K 0.96% 23
2023
Q2 		$5.05M Buy
73,072
+3,774
+5% +$269K 0.94% 26
2023
Q1 		$5.15M Buy
69,298
+9,224
+15% +$773K 0.97% 20
2022
Q4 		$5.6M Buy
60,074
+781
+1% +$75.4K 1.14% 19
2022
Q3 		$5.66M Buy
59,293
+3,200
+6% +$317K 1.36% 14
2022
Q2 		$5.2M Buy
56,093
+196
+0.4% +$19.1K 1.22% 16
2022
Q1 		$5.66M Sell
55,897
-25,437
-31% -$2.67M 1.13% 24
2021
Q4 		$8.39M Sell
81,334
-1,394
-2% -$129K 1.8% 8
2021
Q3 		$7.02M Sell
82,728
-1,190
-1% -$99.7K 2.48% 2
2021
Q2 		$7M Sell
83,918
-151,615
-64% -$12.4M 1.67% 7
2021
Q1 		$6.32M Buy
235,533
+17,440
+8% +$1.27M 1.56% 10
2020
Q4 		$5.89M Buy
+218,093
New +$14.2M 1.74% 5

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cary Street Partners Asset Management's CVS Position: Q2 2024 in Review

Cary Street Partners Asset Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 70,397 shares — an estimated $5.61M sold.

Cary Street Partners Asset Management first reported a position in CVS in Q4 2020 and held it in 14 quarters. The position peaked at $8.39M in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Cary Street Partners Asset Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 70,397 CVS Health shares in Q2 2024, an estimated $5.61M.
  • Cary Street Partners Asset Management first reported a position in CVS Health in Q4 2020 and held it in 14 quarters.
  • Cary Street Partners Asset Management's CVS Health position peaked at $8.39M in Q4 2021.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2024, filed 22 Jul 2024.